Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

BRISTOL, England — As pharmaceutical companies pour billions into developing new Alzheimer’s treatments, researchers at the ...

Aerobic exercise significantly lowers Alzheimer’s disease markers and improves brain health, offering a promising preventive ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...

The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

The search for answers to Alzheimer's disease and other neurodegenerative disorders remains one of the most pressing goals in ...

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...